Previous Close | 55.1 |
1-Year Change | 6.35% |
6-Months Change | -10.64% |
3-Months Change | -8.96% |
Moving Avg (50d) | 58.352 |
Moving Avg (200d) | 62.165 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.07B |
Beta (3-Years) | 0.83 |
Revenue Growth (ttm) | 23.6% |
Net Profit Margin (ttm) | -1.28% |
Return On Assets (ttm) | -0.55% |
EPS (ttm) | -0.57 |
PE Ratio (ttm) | -96.67 |
Dividend Yield | 0.15% |
Asset Description: | ANI Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
56.202 | 57.855 | 58.957 | 60.61 | 63.365 | 66.12 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |